Ralph Toelg

Showing 1-11 of 11 articles

Coronary interventions

Angiographic predictors of unplanned rotational atherectomy in complex calcified coronary artery disease: a pooled analysis from the randomised ROTAXUS and PREPARE-CALC trials

Fitzgerald S, Allali A, Toelg R, Sulimov D, Geist V, Kastrati A, Thiele H, Neumann F, Richardt G, Abdel-Wahab M

October 6, 2021 | 10.4244/EIJ-D-21-00612

Coronary interventions

Outcomes of rotational atherectomy versus modified balloon angioplasty in severely calcified coronary lesions based on target lesion location: a post hoc analysis of the PREPARE-CALC randomised trial

Rheude T, Toelg R, Byrne R, Allali A, Wiebe J, Sulimov D, Voll F, Cassese S, Richardt G, Kastrati A, Abdel-Wahab M

July 17, 2020 | 10.4244/EIJ-D-19-00488

Coronary interventions

Safety and performance of the second-generation drug-eluting absorbable metal scaffold (DREAMS 2G) in patients with de novo coronary lesions: three-year clinical results and angiographic findings of the BIOSOLVE-II first-in-man trial

Haude M, Ince H, Toelg R, Lemos P, von Birgelen C, Christiansen E, Wijns W, Neumann F, Eeckhout E, Garcia-Garcia H, Waksman R

February 7, 2020 | 10.4244/EIJ-D-18-01000

Coronary interventions

BIOFLOW-IV, a randomised, intercontinental, multicentre study to assess the safety and effectiveness of the Orsiro sirolimus-eluting stent in the treatment of subjects with de novo coronary artery lesions: primary outcome target vessel failure at 12 months

Saito S, Toelg R, Witzenbichler B, Haude M, Masotti M, Salmeron R, Witkowski A, Uematsu M, Takahashi A, Waksman R, Slagboom T

December 6, 2019 | 10.4244/EIJ-D-18-01214

Coronary interventions

Sustained safety and clinical performance of a drug-eluting absorbable metal scaffold up to 24 months: pooled outcomes of BIOSOLVE-II and BIOSOLVE-III

Haude M, Ince H, Kische S, Abizaid A, Toelg R, Lemos P, Van Mieghem N, Verheye S, von Birgelen C, Christiansen E, Wijns W, Garcia-Garcia H, Waksman R

July 20, 2017 | 10.4244/EIJ-D-17-00254

Interventions for valvular disease

Impact of femoral artery puncture using digital subtraction angiography and road mapping on vascular and bleeding complications after transfemoral transcatheter aortic valve implantation

El-Mawardy M, Schwarz B, Landt M, Sulimov D, Kebernik J, Allali A, Becker B, Toelg R, Richardt G, Abdel-Wahab M

January 20, 2017 | 10.4244/EIJ-D-15-00412

Coronary artery treatment with paclitaxel-coated balloon using a BTHC excipient: clinical results of the international real-world DELUX registry

Toelg R, Merkely B, Erglis A, Hoffmann S, Bruno H, Kornowski R, Slagboom T, Naber C, Witzenbichler B, Graf K, Richardt G, Hehrlein C

September 28, 2014 | 10.4244/EIJV10I5A102

Comparison of bivalirudin and heparin in patients undergoing rotational atherectomy: a subanalysis of the randomised ROTAXUS trial

Akin I, Khattab A, Buettner H, Toelg R, Geist V, Neumann F, Richardt G, Abdel-Wahab M

August 19, 2014 | 10.4244/EIJV10I4A79

Stuck rotablator: the nightmare of rotational atherectomy

Sulimov D, Abdel-Wahab M, Toelg R, Kassner G, Geist V, Richardt G

June 28, 2013 | 10.4244/EIJV9I2A41

Determination of haemodynamic significance of intermediate coronary lesions using three-dimensional coronary reconstruction

Saad M, Toelg R, Khattab A, Kassner G, Abdel-Wahab M, Richardt G

November 15, 2009 | 10.4244/EIJV5I5A93

Relationship between cardiovascular risk as predicted by established risk scores and coronary artery plaque composition as detected by virtual histology intravascular ultrasound analysis: the PREDICT pilot study

Abdel-Wahab M, Khattab A, Liska B, Toelg R, El-Hammady W, Farag N, Geist V, Ramzy A, Richardt G

January 20, 2008

Latest news

NEW ISSUE

State of the Art on ViV-TAVI; Transseptal Punctures; Endovascular Closure and TF-TAVI; Percutaneous PVL Closure: Long-Term Outcomes; and more

October 20, 2021

STATE OF THE ART

Valve-in-valve TAVI: a practical overview

Giuseppe Tarantini et al.

October 20, 2021

AHEAD OF PRINT

TAVI in younger (<70 years old) patients: the AMTRAC registry

Guy Witberg et al.

October 22, 2021

AHEAD OF PRINT

Impact of LVOT calcification in transfemoral TAVI patients

L. Waldschmidt et al.

Impact of preprocedural biological markers on 10-year mortality in the SYNTAXES trial

Hironori Hara et al.

October 22, 2021

AHEAD OF PRINT

Serum caffeine causes adenosine-induced FFR overestimation

Hideaki Tanaka et al.